54-year-old with pathologically confirmed inflammatory adenoma in left lobe that underwent evaluation by gadoxetate disodium-enhanced MRI. Axial T1-weighted fat-saturated precontrast image shows isointensity to liver of adenoma (arrow). Axial arterial-phase postcontrast image shows hyperintensity to liver (arrow). Axial portal-venous phase postcontrast image shows hyperintensity to liver (arrow). Axial hepatobiliary-phase postcontrast image shows hyperintensity to liver (arrow). Hepatobiliary-phase liver-to

54-year-old with pathologically confirmed inflammatory adenoma in left lobe that underwent evaluation by gadoxetate disodium-enhanced MRI. Axial T1-weighted fat-saturated precontrast image shows isointensity to liver of adenoma (arrow). Axial arterial-phase postcontrast image shows hyperintensity to liver (arrow). Axial portal-venous phase postcontrast image shows hyperintensity to liver (arrow). Axial hepatobiliary-phase postcontrast image shows hyperintensity to liver (arrow). Hepatobiliary-phase liver-to-lesion contrast enhancement ratio is greater than zero, indicating true contrast material retention. 


October 12, 2022 — According to an article in ARRS’ American Journal of Roentgenology (AJR), findings on gadoxetate disodium-enhanced MRI, including hepatobiliary-phase characteristics, were associated with hepatocellular adenomas (HCA) subtypes using the 2017 genotypic classification. 

“The proposed diagnostic algorithm identified common HCA subtypes with high accuracy, including those with β-catenin exon 3 mutations,” wrote first author Justin R. Tse, MD, of Stanford University School of Medicine. “HCAs without features of hepatocyte nuclear factor-1β mutated HCA (H-HCA) or inflammatory HCA (I-HCA)—but with hepatobiliary-phase iso- or hyperintensity—are suspicious for β-catenin exon 3 HCA (β-HCA) or mixed inflammatory and β-catenin exon 3 HCA (βI-HCA), which have increased malignant transformation risk.”  

Dr. Tse and team’s retrospective study included 56 patients (49 women, 7 men; mean age, 37 years) with histologically confirmed HCA evaluated by gadoxetate disodium-enhanced MRI from January 2010 to January 2021. Using 2017 criteria, subtypes were reclassified: H-HCA, I-HCA, β-HCA, βI-HCA, as well as sonic hedgehog HCA (SH-HCA), a newly recognized subtype with the highest risk of symptomatic bleeding. After assessing qualitative MRI features, measuring liver-to-lesion contrast enhancement ratios, and comparing subtypes, the investigators generated a stepwise diagnostic algorithm for determining HCA subtype, based on findings from their present analysis and relevant earlier studies.   

Ultimately, H-HCAs showed homogeneous/diffuse intralesional steatosis in 94% of the cohort. I-HCAs showed atoll sign in 58% and moderate T2-hyperintensity in 58%. Meanwhile, β-HCAs and βI-HCAs occurred in men in 63%, had mean size of 10.1 cm, and showed fluid components in 60% and hepatobiliary-phase iso- or hyperintensity in 80%. The SH-HCA subtype lacked distinguishing characteristics. 

For more information: www.arrs.org 


Related Content

News | Artificial Intelligence

March 1, 2024 — Royal Philips, a global leader in health technology, and magnetic resonance imaging (MRI) software ...

Time March 01, 2024
arrow
News | Ultrasound Imaging

February 15, 2024 — According to the American Journal of Roentgenology (AJR), 10 abdominal radiologists showed ...

Time February 15, 2024
arrow
News | Cardiac Imaging

February 12, 2024 — According to the American Journal of Roentgenology (AJR), free-breathing cine-deep learning (DL) may ...

Time February 12, 2024
arrow
News | Lung Imaging

January 25, 2024 — According to the American Journal of Roentgenology (AJR), high-frequency jet ventilation appears to ...

Time January 25, 2024
arrow
News | Radiology Business

January 25, 2024 — Esaote Group, a leading Italian innovator in medical imaging, today unveiled its new brand identity ...

Time January 25, 2024
arrow
News | Artificial Intelligence

January 23, 2024 — Quibim announced it has added an industry-leading cancer detection capability to its prostate tool ...

Time January 22, 2024
arrow
News | Radiology Business

January 17, 2024 — According to the American Journal of Roentgenology (AJR), the No Surprises Act’s (NSA) independent ...

Time January 17, 2024
arrow
News | Cardiac Imaging

January 11, 2024 — According to the American Journal of Roentgenology (AJR), photon-counting detector (PCD) CT with ...

Time January 11, 2024
arrow
News | Radiology Business

January 3, 2024 — The American Roentgen Ray Society (ARRS) announced that Philip Costello, MD, the 118th ARRS President ...

Time January 03, 2024
arrow
News | Radiology Business

December 27, 2023 — The American Roentgen Ray Society (ARRS) announced David M. Naeger, MD, as the 2024 ARRS ...

Time December 27, 2023
arrow
Subscribe Now